• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆固醇与冠心病。未来方向。

Cholesterol and coronary heart disease. Future directions.

作者信息

Grundy S M

机构信息

Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas 75235-9052.

出版信息

JAMA. 1990 Dec 19;264(23):3053-9.

PMID:2243435
Abstract

The importance of high serum cholesterol levels as a risk factor for coronary heart disease and the benefit of lowering cholesterol levels for reducing risk are being increasingly accepted. A broad consensus to this effect has led to the establishment of the National Cholesterol Education Program. Although the available evidence fully justifies this program, its practical application to the American public has generated a series of new questions that must be explored. For example, it can be questioned whether reduction in coronary risk through lowering cholesterol levels extends to both sexes and all age groups. For people with high cholesterol levels, dietary modification is undoubtedly the first step of management, but the fraction of people responding adequately to dietary change remains to be determined. Finally, indications for drug therapy and choice of drugs need further exploration, particularly in the area of cost vs benefit. Thus, continuing research must be carried out in parallel with clinical and public health application of cholesterol education.

摘要

高血清胆固醇水平作为冠心病危险因素的重要性以及降低胆固醇水平以降低风险的益处正越来越被人们所接受。对此达成的广泛共识促成了国家胆固醇教育计划的设立。尽管现有证据充分证明了该计划的合理性,但其在美国公众中的实际应用引发了一系列必须加以探讨的新问题。例如,通过降低胆固醇水平来降低冠心病风险是否适用于所有性别和所有年龄组就值得质疑。对于胆固醇水平高的人来说,饮食调整无疑是管理的第一步,但对饮食变化有充分反应的人群比例仍有待确定。最后,药物治疗的指征和药物选择需要进一步探索,尤其是在成本与效益方面。因此,在进行胆固醇教育的临床和公共卫生应用的同时,必须开展持续的研究。

相似文献

1
Cholesterol and coronary heart disease. Future directions.胆固醇与冠心病。未来方向。
JAMA. 1990 Dec 19;264(23):3053-9.
2
[The lowering of serum cholesterol in the prevention of coronary disease (part 1). The Canadian Study Group for Periodic Medical Examinations].[血清胆固醇降低在冠心病预防中的作用(第1部分)。加拿大定期体检研究组]
Union Med Can. 1994 Apr;123(4):249-58.
3
Lipid levels. Applying the second National Cholesterol Education Program report to geriatric medicine.血脂水平。将第二次全国胆固醇教育计划报告应用于老年医学。
Geriatrics. 2000 Aug;55(8):48-53; quiz 54.
4
High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.高密度脂蛋白胆固醇和甘油三酯作为预防和治疗冠状动脉疾病的治疗靶点。
Am Heart J. 2002 Dec;144(6 Suppl):S33-42. doi: 10.1067/mhj.2002.130301.
5
Prevention of coronary heart disease through cholesterol reduction.通过降低胆固醇预防冠心病。
Am Fam Physician. 1997 May 1;55(6):2250-8.
6
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.赫尔辛基心脏研究:吉非贝齐用于中年血脂异常男性的一级预防试验。治疗安全性、危险因素变化及冠心病发病率
N Engl J Med. 1987 Nov 12;317(20):1237-45. doi: 10.1056/NEJM198711123172001.
7
LDL-cholesterol as a determinant of coronary heart disease.低密度脂蛋白胆固醇作为冠心病的一个决定因素。
Clin Ther. 1990 Sep-Oct;12(5):370-5; discussion 369.
8
The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association.胆固醇事实。关于膳食脂肪、血清胆固醇与冠心病关系的证据总结。美国心脏协会和国家心肺血液研究所联合声明。美国心脏协会胆固醇问题特别工作组。
Circulation. 1990 May;81(5):1721-33. doi: 10.1161/01.cir.81.5.1721.
9
Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.实现心脏病患者低密度脂蛋白胆固醇的国家胆固醇教育计划目标:饮食、运动、体重控制和药物治疗的重要性。
Mayo Clin Proc. 1999 May;74(5):466-73. doi: 10.4065/74.5.466.
10
A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.老年人血脂水平与冠心病的长期随访研究
Chin Med J (Engl). 2004 Feb;117(2):163-7.

引用本文的文献

1
Native low-density lipoprotein-dependent interleukin-8 production through pertussis toxin-sensitive G-protein coupled receptors and hydrogen peroxide generation contributes to migration of human aortic smooth muscle cells.内源性低密度脂蛋白依赖性白细胞介素-8 通过百日咳毒素敏感 G 蛋白偶联受体和过氧化氢生成促进人主动脉平滑肌细胞迁移。
Yonsei Med J. 2011 May;52(3):413-9. doi: 10.3349/ymj.2011.52.3.413.
2
Membrane topology of human NPC1L1, a key protein in enterohepatic cholesterol absorption.人NPC1L1的膜拓扑结构,肠肝循环中胆固醇吸收的关键蛋白。
J Lipid Res. 2009 Aug;50(8):1653-62. doi: 10.1194/jlr.M800669-JLR200. Epub 2009 Mar 26.
3
Who should receive HMG CoA reductase inhibitors?
哪些人应该接受HMG辅酶A还原酶抑制剂治疗?
Drugs. 2002;62(12):1707-15. doi: 10.2165/00003495-200262120-00001.
4
The health of Cree, Inuit and southern Quebec women: similarities and differences.克里族、因纽特族和魁北克南部女性的健康状况:异同点
Can J Public Health. 2000 May-Jun;91(3):212-6. doi: 10.1007/BF03404274.
5
Effect of cyclodextrins and undigested starch on the loss of chenodeoxycholate in the faeces.环糊精和未消化淀粉对粪便中鹅去氧胆酸盐流失的影响。
Biochem J. 1994 May 1;299 ( Pt 3)(Pt 3):725-30. doi: 10.1042/bj2990725.
6
Efficacy and safety of fluvastatin in women with primary hypercholesterolaemia.氟伐他汀治疗原发性高胆固醇血症女性患者的疗效与安全性。
Drugs. 1994;47 Suppl 2:64-72. doi: 10.2165/00003495-199400472-00012.
7
Cholesterol and coronary disease--outstanding questions.
Cardiovasc Drugs Ther. 1992 Apr;6(2):131-6. doi: 10.1007/BF00054559.